Research Topic

Non-immunogenic cancers have best outcomes—according to findings at the Anesthesiology 2021 annual meeting of a large retrospective study comparing 90-day survival.

The U.S. Food and Drug Administration told the company Friday evening that its review could last until January, Moderna said.

University researchers and drug developers in Edmonton are joining forces to create what they say will be Canada's first facility that can take the latest scientific pharmaceutical insights from the lab through clinical trials to the marketplace.

Strong relationships with patients often make pharmacists first line of access when questions or issues arise

Post-acute COVID-19 syndrome describes patients that have lingering symptoms (e.g., 12 weeks or longer) after the start of acute COVID‑19.

Study also finds cancer patients with no recent cancer treatment have similar or better COVID-19 outcomes than those without cancer.

This year's iteration of the organization's annual survey is open until Nov. 15.

As little as 15 minutes a day of brisk walking could help many women who struggle with postpartum depression, according to a study from Western University.